Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers November 18, 2017
Pharmacy Choice - Pharmaceutical News - Biosimilars Market Access in Psoriatic Arthritis 2017 - Payers are Unlikely to Implement Strong Incentives to Drive Uptake of Biosimilar Infliximab Due to Limited Use of the Drug - Research and Markets - November 18, 2017

Pharmacy News Article

 5/18/17 - Biosimilars Market Access in Psoriatic Arthritis 2017 - Payers are Unlikely to Implement Strong Incentives to Drive Uptake of Biosimilar Infliximab Due to Limited Use of the Drug - Research and Markets

DUBLIN, May 18, 2017 /PRNewswire/

Research and Markets has announced the addition of the "Biosimilars Market Access in Psoriatic Arthritis" report to their offering.

Research and Markets Logo

Tumor necrosis factor (TNF)-alpha inhibitors Enbrel, Humira, and Remicade have long held dominant positions in the psoriatic arthritis market. These market leaders, however, face patent expirations and consequent biosimilar launches.

Payers are eager to leverage these changes in the competitive landscape and enact pro-biosimilar access measures, resulting in downward pricing pressures and/or continuing market erosion for first-generation TNF-alpha inhibitors.

The rate of this erosion is likely to be gradual initially, as both physicians and payers are not likely to advocate patient switching.

Key Topics Covered:

1. Executive Summary

  • Inflectra carries biosimilar labeling designation, but is not interchangeable
  • Physicians hesitant to use biosimilars, but understand that payers may hold sway
  • Bibliography

2. Five Major EU Markets

  • Insights and strategic recommendations
  • Uptake of biosimilar TNF-alpha inhibitors varies across EU markets as the EMA does not determine interchangeability
  • Most physicians and payers consider biosimilars to be interchangeable, and an opportunity to reduce costs, but worries around indication extrapolation remain
  • Payers use biosimilars to pressure originators on pricing
  • Hospitals continue to procure both biosimilars and originators; dynamic pricing environment observed
  • Biosimilars will be used as price benchmarks for pipeline agents
  • Payers are unlikely to implement strong incentives to drive uptake of biosimilar infliximab due to limited use of the drug
  • Bibliography

3. Methodology

  • Primary research

For more information about this report visit http://www.researchandmarkets.com/research/8gznkc/biosimilars

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716



To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/biosimilars-market-access-in-psoriatic-arthritis-2017-payers-are-unlikely-to-implement-strong-incentives-to-drive-uptake-of-biosimilar-infliximab-due-to-limited-use-of-the-drug-research-and-markets-300459960.html

SOURCE Research and Markets




Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Last Chance
Nov 19: Biosimilar Drugs: Legal, Regulatory & Safety Considerations
Nov 20: Obesity Management: Overview of Pharmacotherapy
Nov 21: Standards of Practice for Filling Controlled Substance Prescriptions in Florida
Nov 22: Medical Marijuana: Examining the Science, Not the Politics
Nov 27: Drug Diversion and the Law: Updates and Considerations
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415